EUVIMEDEUVIMED entdecken
Open Access · CC0

Estimating the effect of anticipated depression treatment-related stigma on depression remission among people with noncommunicable diseases and depressive symptoms in Malawi

Josée M Dussault iD, Chifundo Zimba, Harriet Akello, Melissa Stockton iD, Sherika Hill, Allison E Aiello, Alexander Keil iD, Bradley N Gaynes, Michael Udedi iD, Brian W Pence

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0282016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Josée M Dussault und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC, United States of America. Hauptthemen laut MEDLINE: Depression, Noncommunicable Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

While mental health stigma research is sparse in Malawi, research in other settings suggests that stigma represents a barrier to mental health treatment and recovery. Accordingly, we conducted an analysis to understand the role of treatment-related stigma in depression care in Malawi by estimating the effect of patients’ baseline anticipated treatment-related stigma on their 3-month probability of depression remission when newly identified with depression.

Methods

We conducted depression screening and treatment at 10 noncommunicable disease (NCD) clinics across Malawi from April 2019 through December 2021. Eligible cohort participants were 18–65 years with depressive symptoms indicated by a PHQ-9 score ≥5. Questionnaires at the baseline and 3-month interviews included a vignette-based quantitative stigma instrument that measured treatment-related stigma, i.e., concerns about external stigma because of receiving depression treatment. Using inverse probability weighting to adjust for confounding and multiple imputation to account for missing data, this analysis relates participants’ baseline levels of anticipated treatment stigma to the 3-month probability of achieving depression remission (i.e., PHQ-9 score < 5).

Results

Of 743 included participants, 273 (37%) achieved depression remission by their 3-month interview. The probability of achieving depression remission at the 3-month interview among participants with high anticipated treatment stigma (0.31; 95% Confidence Interval [CI]: 0.23, 0.39)) was 10 percentage points lower than among the low/neutral stigma group (risk: 0.41; 95% CI: 0.36, 0.45; RD: -0.10; 95% CI: -0.19, -0.003).

Conclusion

In Malawi, a reduction in anticipated depression treatment-related stigma among NCD patients initiating depression treatment could improve depression outcomes. Further investigation is necessary to understand the modes by which stigma can be successfully reduced to improve mental health outcomes and quality of life among people living with depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionNoncommunicable DiseasesHumansMalawiQuality of LifeSocial Stigma

Autor:innen und Institutionen

  • Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC, United States of America.
  • UNC Project Malawi, Lilongwe, Malawi.
  • Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States of America.
  • New York State Psychiatric Institute, New York, New York, United States of America.
  • Center for Child and Family Policy, Duke University, Durham, NC, United States of America.
  • Department of Epidemiology and Robert N. Butler Columbia Aging Center, Columbia University Mailman School of Public Health, New York, New York, United States of America.

ORCID-Profile: Josée M Dussault, Melissa Stockton, Alexander Keil, Michael Udedi

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS
  • NIMH NIH HHS
  • National Institute of Mental Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Dussault, J. M., Zimba, C., Akello, H., Stockton, M., Hill, S., Aiello, A. E., Keil, A., Gaynes, B. N., Udedi, M., & Pence, B. W. (2023). Estimating the effect of anticipated depression treatment-related stigma on depression remission among people with noncommunicable diseases and depressive symptoms in Malawi. PLOS ONE. https://doi.org/10.1371/journal.pone.0282016

Vancouver

Dussault JM, Zimba C, Akello H, Stockton M, Hill S, Aiello AE, et al. Estimating the effect of anticipated depression treatment-related stigma on depression remission among people with noncommunicable diseases and depressive symptoms in Malawi. PLOS ONE. 2023. doi:10.1371/journal.pone.0282016

BibTeX
@article{Dussault2023,
  author = {Dussault, Josée M and Zimba, Chifundo and Akello, Harriet and Stockton, Melissa and Hill, Sherika and Aiello, Allison E and Keil, Alexander and Gaynes, Bradley N and Udedi, Michael and Pence, Brian W},
  title = {Estimating the effect of anticipated depression treatment-related stigma on depression remission among people with noncommunicable diseases and depressive symptoms in Malawi},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0282016}
}
Kostenlos starten →